XenoPort, Inc. (NASDAQ:XNPT)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs.

Recs

0
Player Avatar AndrewGreenBull (99.06) Submitted: 4/5/2011 11:18:05 AM : Underperform Start Price: $6.58 XNPT Score: +9.58

probably another CRL

Report this Post 1 Comment
Member Avatar senatorquijano (< 20) Submitted: 4/7/2011 4:46:00 PM
Recs: 0

yikes

Featured Broker Partners


Advertisement